1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prescription Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Original Brand Drug 1.2.3 Generic Drug 1.3 Market by Application 1.3.1 Global Prescription Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Online 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prescription Medicine Market Perspective (2017-2028) 2.2 Prescription Medicine Growth Trends by Region 2.2.1 Prescription Medicine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Prescription Medicine Historic Market Size by Region (2017-2022) 2.2.3 Prescription Medicine Forecasted Market Size by Region (2023-2028) 2.3 Prescription Medicine Market Dynamics 2.3.1 Prescription Medicine Industry Trends 2.3.2 Prescription Medicine Market Drivers 2.3.3 Prescription Medicine Market Challenges 2.3.4 Prescription Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prescription Medicine Players by Revenue 3.1.1 Global Top Prescription Medicine Players by Revenue (2017-2022) 3.1.2 Global Prescription Medicine Revenue Market Share by Players (2017-2022) 3.2 Global Prescription Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Prescription Medicine Revenue 3.4 Global Prescription Medicine Market Concentration Ratio 3.4.1 Global Prescription Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prescription Medicine Revenue in 2021 3.5 Prescription Medicine Key Players Head office and Area Served 3.6 Key Players Prescription Medicine Product Solution and Service 3.7 Date of Enter into Prescription Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prescription Medicine Breakdown Data by Type 4.1 Global Prescription Medicine Historic Market Size by Type (2017-2022) 4.2 Global Prescription Medicine Forecasted Market Size by Type (2023-2028) 5 Prescription Medicine Breakdown Data by Application 5.1 Global Prescription Medicine Historic Market Size by Application (2017-2022) 5.2 Global Prescription Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Prescription Medicine Market Size (2017-2028) 6.2 North America Prescription Medicine Market Size by Type 6.2.1 North America Prescription Medicine Market Size by Type (2017-2022) 6.2.2 North America Prescription Medicine Market Size by Type (2023-2028) 6.2.3 North America Prescription Medicine Market Share by Type (2017-2028) 6.3 North America Prescription Medicine Market Size by Application 6.3.1 North America Prescription Medicine Market Size by Application (2017-2022) 6.3.2 North America Prescription Medicine Market Size by Application (2023-2028) 6.3.3 North America Prescription Medicine Market Share by Application (2017-2028) 6.4 North America Prescription Medicine Market Size by Country 6.4.1 North America Prescription Medicine Market Size by Country (2017-2022) 6.4.2 North America Prescription Medicine Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Prescription Medicine Market Size (2017-2028) 7.2 Europe Prescription Medicine Market Size by Type 7.2.1 Europe Prescription Medicine Market Size by Type (2017-2022) 7.2.2 Europe Prescription Medicine Market Size by Type (2023-2028) 7.2.3 Europe Prescription Medicine Market Share by Type (2017-2028) 7.3 Europe Prescription Medicine Market Size by Application 7.3.1 Europe Prescription Medicine Market Size by Application (2017-2022) 7.3.2 Europe Prescription Medicine Market Size by Application (2023-2028) 7.3.3 Europe Prescription Medicine Market Share by Application (2017-2028) 7.4 Europe Prescription Medicine Market Size by Country 7.4.1 Europe Prescription Medicine Market Size by Country (2017-2022) 7.4.2 Europe Prescription Medicine Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Prescription Medicine Market Size (2017-2028) 8.2 Asia-Pacific Prescription Medicine Market Size by Type 8.2.1 Asia-Pacific Prescription Medicine Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Prescription Medicine Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Prescription Medicine Market Share by Type (2017-2028) 8.3 Asia-Pacific Prescription Medicine Market Size by Application 8.3.1 Asia-Pacific Prescription Medicine Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Prescription Medicine Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Prescription Medicine Market Share by Application (2017-2028) 8.4 Asia-Pacific Prescription Medicine Market Size by Region 8.4.1 Asia-Pacific Prescription Medicine Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Prescription Medicine Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prescription Medicine Market Size (2017-2028) 9.2 Latin America Prescription Medicine Market Size by Type 9.2.1 Latin America Prescription Medicine Market Size by Type (2017-2022) 9.2.2 Latin America Prescription Medicine Market Size by Type (2023-2028) 9.2.3 Latin America Prescription Medicine Market Share by Type (2017-2028) 9.3 Latin America Prescription Medicine Market Size by Application 9.3.1 Latin America Prescription Medicine Market Size by Application (2017-2022) 9.3.2 Latin America Prescription Medicine Market Size by Application (2023-2028) 9.3.3 Latin America Prescription Medicine Market Share by Application (2017-2028) 9.4 Latin America Prescription Medicine Market Size by Country 9.4.1 Latin America Prescription Medicine Market Size by Country (2017-2022) 9.4.2 Latin America Prescription Medicine Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prescription Medicine Market Size (2017-2028) 10.2 Middle East & Africa Prescription Medicine Market Size by Type 10.2.1 Middle East & Africa Prescription Medicine Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Prescription Medicine Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Prescription Medicine Market Share by Type (2017-2028) 10.3 Middle East & Africa Prescription Medicine Market Size by Application 10.3.1 Middle East & Africa Prescription Medicine Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Prescription Medicine Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Prescription Medicine Market Share by Application (2017-2028) 10.4 Middle East & Africa Prescription Medicine Market Size by Country 10.4.1 Middle East & Africa Prescription Medicine Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Prescription Medicine Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Prescription Medicine Introduction 11.1.4 Pfizer Revenue in Prescription Medicine Business (2017-2022) 11.1.5 Pfizer Recent Developments 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche Prescription Medicine Introduction 11.2.4 Roche Revenue in Prescription Medicine Business (2017-2022) 11.2.5 Roche Recent Developments 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Prescription Medicine Introduction 11.3.4 Novartis Revenue in Prescription Medicine Business (2017-2022) 11.3.5 Novartis Recent Developments 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Details 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Prescription Medicine Introduction 11.4.4 Johnson & Johnson Revenue in Prescription Medicine Business (2017-2022) 11.4.5 Johnson & Johnson Recent Developments 11.5 Merck & Co. 11.5.1 Merck & Co. Company Details 11.5.2 Merck & Co. Business Overview 11.5.3 Merck & Co. Prescription Medicine Introduction 11.5.4 Merck & Co. Revenue in Prescription Medicine Business (2017-2022) 11.5.5 Merck & Co. Recent Developments 11.6 Sanofi 11.6.1 Sanofi Company Details 11.6.2 Sanofi Business Overview 11.6.3 Sanofi Prescription Medicine Introduction 11.6.4 Sanofi Revenue in Prescription Medicine Business (2017-2022) 11.6.5 Sanofi Recent Developments 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Prescription Medicine Introduction 11.7.4 AbbVie Revenue in Prescription Medicine Business (2017-2022) 11.7.5 AbbVie Recent Developments 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 GlaxoSmithKline Business Overview 11.8.3 GlaxoSmithKline Prescription Medicine Introduction 11.8.4 GlaxoSmithKline Revenue in Prescription Medicine Business (2017-2022) 11.8.5 GlaxoSmithKline Recent Developments 11.9 Amgen 11.9.1 Amgen Company Details 11.9.2 Amgen Business Overview 11.9.3 Amgen Prescription Medicine Introduction 11.9.4 Amgen Revenue in Prescription Medicine Business (2017-2022) 11.9.5 Amgen Recent Developments 11.10 Gilead Science 11.10.1 Gilead Science Company Details 11.10.2 Gilead Science Business Overview 11.10.3 Gilead Science Prescription Medicine Introduction 11.10.4 Gilead Science Revenue in Prescription Medicine Business (2017-2022) 11.10.5 Gilead Science Recent Developments 11.11 Bristol-Myers Squibb 11.11.1 Bristol-Myers Squibb Company Details 11.11.2 Bristol-Myers Squibb Business Overview 11.11.3 Bristol-Myers Squibb Prescription Medicine Introduction 11.11.4 Bristol-Myers Squibb Revenue in Prescription Medicine Business (2017-2022) 11.11.5 Bristol-Myers Squibb Recent Developments 11.12 AstraZeneca 11.12.1 AstraZeneca Company Details 11.12.2 AstraZeneca Business Overview 11.12.3 AstraZeneca Prescription Medicine Introduction 11.12.4 AstraZeneca Revenue in Prescription Medicine Business (2017-2022) 11.12.5 AstraZeneca Recent Developments 11.13 Eli Lilly 11.13.1 Eli Lilly Company Details 11.13.2 Eli Lilly Business Overview 11.13.3 Eli Lilly Prescription Medicine Introduction 11.13.4 Eli Lilly Revenue in Prescription Medicine Business (2017-2022) 11.13.5 Eli Lilly Recent Developments 11.14 Bayer 11.14.1 Bayer Company Details 11.14.2 Bayer Business Overview 11.14.3 Bayer Prescription Medicine Introduction 11.14.4 Bayer Revenue in Prescription Medicine Business (2017-2022) 11.14.5 Bayer Recent Developments 11.15 Novo Nordisk 11.15.1 Novo Nordisk Company Details 11.15.2 Novo Nordisk Business Overview 11.15.3 Novo Nordisk Prescription Medicine Introduction 11.15.4 Novo Nordisk Revenue in Prescription Medicine Business (2017-2022) 11.15.5 Novo Nordisk Recent Developments 11.16 Takeda 11.16.1 Takeda Company Details 11.16.2 Takeda Business Overview 11.16.3 Takeda Prescription Medicine Introduction 11.16.4 Takeda Revenue in Prescription Medicine Business (2017-2022) 11.16.5 Takeda Recent Developments 11.17 Boehringer-Ingelheim 11.17.1 Boehringer-Ingelheim Company Details 11.17.2 Boehringer-Ingelheim Business Overview 11.17.3 Boehringer-Ingelheim Prescription Medicine Introduction 11.17.4 Boehringer-Ingelheim Revenue in Prescription Medicine Business (2017-2022) 11.17.5 Boehringer-Ingelheim Recent Developments 11.18 Allergan 11.18.1 Allergan Company Details 11.18.2 Allergan Business Overview 11.18.3 Allergan Prescription Medicine Introduction 11.18.4 Allergan Revenue in Prescription Medicine Business (2017-2022) 11.18.5 Allergan Recent Developments 11.19 Teva Pharmaceutical Industries 11.19.1 Teva Pharmaceutical Industries Company Details 11.19.2 Teva Pharmaceutical Industries Business Overview 11.19.3 Teva Pharmaceutical Industries Prescription Medicine Introduction 11.19.4 Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2017-2022) 11.19.5 Teva Pharmaceutical Industries Recent Developments 11.20 Mylan 11.20.1 Mylan Company Details 11.20.2 Mylan Business Overview 11.20.3 Mylan Prescription Medicine Introduction 11.20.4 Mylan Revenue in Prescription Medicine Business (2017-2022) 11.20.5 Mylan Recent Developments 11.21 Astellas Pharma 11.21.1 Astellas Pharma Company Details 11.21.2 Astellas Pharma Business Overview 11.21.3 Astellas Pharma Prescription Medicine Introduction 11.21.4 Astellas Pharma Revenue in Prescription Medicine Business (2017-2022) 11.21.5 Astellas Pharma Recent Developments 11.22 Biogen 11.22.1 Biogen Company Details 11.22.2 Biogen Business Overview 11.22.3 Biogen Prescription Medicine Introduction 11.22.4 Biogen Revenue in Prescription Medicine Business (2017-2022) 11.22.5 Biogen Recent Developments 11.23 CSL 11.23.1 CSL Company Details 11.23.2 CSL Business Overview 11.23.3 CSL Prescription Medicine Introduction 11.23.4 CSL Revenue in Prescription Medicine Business (2017-2022) 11.23.5 CSL Recent Developments 11.24 Daiichi Sankyo 11.24.1 Daiichi Sankyo Company Details 11.24.2 Daiichi Sankyo Business Overview 11.24.3 Daiichi Sankyo Prescription Medicine Introduction 11.24.4 Daiichi Sankyo Revenue in Prescription Medicine Business (2017-2022) 11.24.5 Daiichi Sankyo Recent Developments 11.25 Otsuka Holdings 11.25.1 Otsuka Holdings Company Details 11.25.2 Otsuka Holdings Business Overview 11.25.3 Otsuka Holdings Prescription Medicine Introduction 11.25.4 Otsuka Holdings Revenue in Prescription Medicine Business (2017-2022) 11.25.5 Otsuka Holdings Recent Developments 11.26 UCB 11.26.1 UCB Company Details 11.26.2 UCB Business Overview 11.26.3 UCB Prescription Medicine Introduction 11.26.4 UCB Revenue in Prescription Medicine Business (2017-2022) 11.26.5 UCB Recent Developments 11.27 LES LABORATOIRES SERVIER 11.27.1 LES LABORATOIRES SERVIER Company Details 11.27.2 LES LABORATOIRES SERVIER Business Overview 11.27.3 LES LABORATOIRES SERVIER Prescription Medicine Introduction 11.27.4 LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2017-2022) 11.27.5 LES LABORATOIRES SERVIER Recent Developments 11.28 Bausch Health Companies 11.28.1 Bausch Health Companies Company Details 11.28.2 Bausch Health Companies Business Overview 11.28.3 Bausch Health Companies Prescription Medicine Introduction 11.28.4 Bausch Health Companies Revenue in Prescription Medicine Business (2017-2022) 11.28.5 Bausch Health Companies Recent Developments 11.29 Eisai 11.29.1 Eisai Company Details 11.29.2 Eisai Business Overview 11.29.3 Eisai Prescription Medicine Introduction 11.29.4 Eisai Revenue in Prescription Medicine Business (2017-2022) 11.29.5 Eisai Recent Developments 11.30 Abbott Laboratories 11.30.1 Abbott Laboratories Company Details 11.30.2 Abbott Laboratories Business Overview 11.30.3 Abbott Laboratories Prescription Medicine Introduction 11.30.4 Abbott Laboratories Revenue in Prescription Medicine Business (2017-2022) 11.30.5 Abbott Laboratories Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Prescription Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Original Brand Drug Table 3. Key Players of Generic Drug Table 4. Global Prescription Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Prescription Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Prescription Medicine Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Prescription Medicine Market Share by Region (2017-2022) Table 8. Global Prescription Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Prescription Medicine Market Share by Region (2023-2028) Table 10. Prescription Medicine Market Trends Table 11. Prescription Medicine Market Drivers Table 12. Prescription Medicine Market Challenges Table 13. Prescription Medicine Market Restraints Table 14. Global Prescription Medicine Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Prescription Medicine Revenue Share by Players (2017-2022) Table 16. Global Top Prescription Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2021) Table 17. Ranking of Global Top Prescription Medicine Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Prescription Medicine Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prescription Medicine Product Solution and Service Table 21. Date of Enter into Prescription Medicine Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Prescription Medicine Revenue Market Share by Type (2017-2022) Table 25. Global Prescription Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Prescription Medicine Revenue Market Share by Type (2023-2028) Table 27. Global Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Prescription Medicine Revenue Share by Application (2017-2022) Table 29. Global Prescription Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Prescription Medicine Revenue Share by Application (2023-2028) Table 31. North America Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Prescription Medicine Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Prescription Medicine Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Prescription Medicine Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Prescription Medicine Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Prescription Medicine Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Prescription Medicine Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Prescription Medicine Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Prescription Medicine Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Prescription Medicine Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Prescription Medicine Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Prescription Medicine Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Prescription Medicine Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Prescription Medicine Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Prescription Medicine Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Prescription Medicine Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Prescription Medicine Market Size by Country (2023-2028) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Prescription Medicine Product Table 64. Pfizer Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 65. Pfizer Recent Developments Table 66. Roche Company Details Table 67. Roche Business Overview Table 68. Roche Prescription Medicine Product Table 69. Roche Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 70. Roche Recent Developments Table 71. Novartis Company Details Table 72. Novartis Business Overview Table 73. Novartis Prescription Medicine Product Table 74. Novartis Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 75. Novartis Recent Developments Table 76. Johnson & Johnson Company Details Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Prescription Medicine Product Table 79. Johnson & Johnson Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 80. Johnson & Johnson Recent Developments Table 81. Merck & Co. Company Details Table 82. Merck & Co. Business Overview Table 83. Merck & Co. Prescription Medicine Product Table 84. Merck & Co. Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 85. Merck & Co. Recent Developments Table 86. Sanofi Company Details Table 87. Sanofi Business Overview Table 88. Sanofi Prescription Medicine Product Table 89. Sanofi Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 90. Sanofi Recent Developments Table 91. AbbVie Company Details Table 92. AbbVie Business Overview Table 93. AbbVie Prescription Medicine Product Table 94. AbbVie Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 95. AbbVie Recent Developments Table 96. GlaxoSmithKline Company Details Table 97. GlaxoSmithKline Business Overview Table 98. GlaxoSmithKline Prescription Medicine Product Table 99. GlaxoSmithKline Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 100. GlaxoSmithKline Recent Developments Table 101. Amgen Company Details Table 102. Amgen Business Overview Table 103. Amgen Prescription Medicine Product Table 104. Amgen Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 105. Amgen Recent Developments Table 106. Gilead Science Company Details Table 107. Gilead Science Business Overview Table 108. Gilead Science Prescription Medicine Product Table 109. Gilead Science Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 110. Gilead Science Recent Developments Table 111. Bristol-Myers Squibb Company Details Table 112. Bristol-Myers Squibb Business Overview Table 113. Bristol-Myers Squibb Prescription Medicine Product Table 114. Bristol-Myers Squibb Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 115. Bristol-Myers Squibb Recent Developments Table 116. AstraZeneca Company Details Table 117. AstraZeneca Business Overview Table 118. AstraZeneca Prescription Medicine Product Table 119. AstraZeneca Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 120. AstraZeneca Recent Developments Table 121. Eli Lilly Company Details Table 122. Eli Lilly Business Overview Table 123. Eli Lilly Prescription Medicine Product Table 124. Eli Lilly Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 125. Eli Lilly Recent Developments Table 126. Bayer Company Details Table 127. Bayer Business Overview Table 128. Bayer Prescription Medicine Product Table 129. Bayer Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 130. Bayer Recent Developments Table 131. Novo Nordisk Company Details Table 132. Novo Nordisk Business Overview Table 133. Novo Nordisk Prescription Medicine Product Table 134. Novo Nordisk Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 135. Novo Nordisk Recent Developments Table 136. Takeda Company Details Table 137. Takeda Business Overview Table 138. Takeda Prescription Medicine Product Table 139. Takeda Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 140. Takeda Recent Developments Table 141. Boehringer-Ingelheim Company Details Table 142. Boehringer-Ingelheim Business Overview Table 143. Boehringer-Ingelheim Prescription Medicine Product Table 144. Boehringer-Ingelheim Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 145. Boehringer-Ingelheim Recent Developments Table 146. Allergan Company Details Table 147. Allergan Business Overview Table 148. Allergan Prescription Medicine Product Table 149. Allergan Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 150. Allergan Recent Developments Table 151. Teva Pharmaceutical Industries Company Details Table 152. Teva Pharmaceutical Industries Business Overview Table 153. Teva Pharmaceutical Industries Prescription Medicine Product Table 154. Teva Pharmaceutical Industries Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 155. Teva Pharmaceutical Industries Recent Developments Table 156. Mylan Company Details Table 157. Mylan Business Overview Table 158. Mylan Prescription Medicine Product Table 159. Mylan Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 160. Mylan Recent Developments Table 161. Astellas Pharma Company Details Table 162. Astellas Pharma Business Overview Table 163. Astellas Pharma Prescription Medicine Product Table 164. Astellas Pharma Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 165. Astellas Pharma Recent Developments Table 166. Biogen Company Details Table 167. Biogen Business Overview Table 168. Biogen Prescription Medicine Product Table 169. Biogen Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 170. Biogen Recent Developments Table 171. CSL Company Details Table 172. CSL Business Overview Table 173. CSL Prescription Medicine Product Table 174. CSL Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 175. CSL Recent Developments Table 176. Daiichi Sankyo Company Details Table 177. Daiichi Sankyo Business Overview Table 178. Daiichi Sankyo Prescription Medicine Product Table 179. Daiichi Sankyo Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 180. Daiichi Sankyo Recent Developments Table 181. Otsuka Holdings Company Details Table 182. Otsuka Holdings Business Overview Table 183. Otsuka Holdings Prescription Medicine Product Table 184. Otsuka Holdings Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 185. Otsuka Holdings Recent Developments Table 186. UCB Company Details Table 187. UCB Business Overview Table 188. UCB Prescription Medicine Product Table 189. UCB Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 190. UCB Recent Developments Table 191. LES LABORATOIRES SERVIER Company Details Table 192. LES LABORATOIRES SERVIER Business Overview Table 193. LES LABORATOIRES SERVIER Prescription Medicine Product Table 194. LES LABORATOIRES SERVIER Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 195. LES LABORATOIRES SERVIER Recent Developments Table 196. Bausch Health Companies Company Details Table 197. Bausch Health Companies Business Overview Table 198. Bausch Health Companies Prescription Medicine Product Table 199. Bausch Health Companies Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 200. Bausch Health Companies Recent Developments Table 201. Eisai Company Details Table 202. Eisai Business Overview Table 203. Eisai Prescription Medicine Product Table 204. Eisai Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 205. Eisai Recent Developments Table 206. Abbott Laboratories Company Details Table 207. Abbott Laboratories Business Overview Table 208. Abbott Laboratories Prescription Medicine Product Table 209. Abbott Laboratories Revenue in Prescription Medicine Business (2017-2022) & (US$ Million) Table 210. Abbott Laboratories Recent Developments Table 211. Research Programs/Design for This Report Table 212. Key Data Information from Secondary Sources Table 213. Key Data Information from Primary Sources List of Figures Figure 1. Global Prescription Medicine Market Share by Type: 2021 VS 2028 Figure 2. Original Brand Drug Features Figure 3. Generic Drug Features Figure 4. Global Prescription Medicine Market Share by Application: 2021 VS 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Online Case Studies Figure 8. Others Case Studies Figure 9. Prescription Medicine Report Years Considered Figure 10. Global Prescription Medicine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Prescription Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Prescription Medicine Market Share by Region: 2021 VS 2028 Figure 13. Global Prescription Medicine Market Share by Players in 2021 Figure 14. Global Top Prescription Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Medicine as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Prescription Medicine Revenue in 2021 Figure 16. North America Prescription Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Prescription Medicine Market Size Market Share by Type (2017-2028) Figure 18. North America Prescription Medicine Market Size Market Share by Application (2017-2028) Figure 19. North America Prescription Medicine Market Size Share by Country (2017-2028) Figure 20. United States Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Prescription Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Prescription Medicine Market Size Market Share by Type (2017-2028) Figure 24. Europe Prescription Medicine Market Size Market Share by Application (2017-2028) Figure 25. Europe Prescription Medicine Market Size Share by Country (2017-2028) Figure 26. Germany Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Prescription Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Prescription Medicine Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Prescription Medicine Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Prescription Medicine Market Size Share by Region (2017-2028) Figure 36. China Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Prescription Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Prescription Medicine Market Size Market Share by Type (2017-2028) Figure 44. Latin America Prescription Medicine Market Size Market Share by Application (2017-2028) Figure 45. Latin America Prescription Medicine Market Size Share by Country (2017-2028) Figure 46. Mexico Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Prescription Medicine Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Prescription Medicine Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Prescription Medicine Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Prescription Medicine Market Size Share by Country (2017-2028) Figure 52. Turkey Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Prescription Medicine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Pfizer Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 56. Roche Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 57. Novartis Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 58. Johnson & Johnson Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 59. Merck & Co. Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 60. Sanofi Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 61. AbbVie Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 62. GlaxoSmithKline Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 63. Amgen Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 64. Gilead Science Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 66. AstraZeneca Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 67. Eli Lilly Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 68. Bayer Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 69. Novo Nordisk Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 70. Takeda Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 71. Boehringer-Ingelheim Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 72. Allergan Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 73. Teva Pharmaceutical Industries Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 74. Mylan Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 75. Astellas Pharma Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 76. Biogen Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 77. CSL Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 78. Daiichi Sankyo Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 79. Otsuka Holdings Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 80. UCB Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 81. LES LABORATOIRES SERVIER Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 82. Bausch Health Companies Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 83. Eisai Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 84. Abbott Laboratories Revenue Growth Rate in Prescription Medicine Business (2017-2022) Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed

Pfizer Roche Novartis Johnson & Johnson Merck & Co. Sanofi AbbVie GlaxoSmithKline Amgen Gilead Science Bristol-Myers Squibb AstraZeneca Eli Lilly Bayer Novo Nordisk Takeda Boehringer-Ingelheim Allergan Teva Pharmaceutical Industries Mylan Astellas Pharma Biogen CSL Daiichi Sankyo Otsuka Holdings UCB LES LABORATOIRES SERVIER Bausch Health Companies Eisai Abbott Laboratories